Cited by 8Urticaria and Related ConditionsMast cells and histamineEosinophilic Disorders and Syndromes

Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients

Open access
Neisinger, Sophia, Salameh, Pascale, Gutsche, Annika, Aulenbacher, Felix, Siebenhaar, Frank, Maurer, Marcus·2025·Clinical and Translational Allergy

Abstract

Background: Patient‐reported outcome measures (PROMs) help to assess disease control and quality of life (QoL) in chronic spontaneous urticaria (CSU) and recurrent angioedema (RA). This study aimed to assess the correlation between two different concepts: disease control and QoL, using disease‐specific PROMs. Methods: We analyzed data from 445 CSU and 330 RA patients who completed both a disease control and QoL PROM as part of the clinical routine. We included the UCT and CU‐Q2oL for CSU and AECT and AE‐QoL for RA. Results: In CSU and RA, disease control scores positively correlated with QoL scores (Spearman's rho correlation coefficient (CR) −0.757, −0.735; p < 0.001) with better disease control corresponding to better quality of life. However, 5.9% of CSU patients and 28% of RA patients with complete disease control had impaired QoL. In CSU, QoL was impaired in 69.2% of patients based on the CU‐Q2oL and in 62.7% of patients based on a single numeric question from the UCT, with a mismatch in 89/445 patients. In RA, QoL was impaired in 58.5% using the AE‐QoL and in 52.7% using a single numeric question from the AECT30mo, with a mismatch in 69/330 patients. Different domains of the QoL PROMs showed different degrees of influence on disease control, with “Itching/Embarrassment” showing the strongest correlation with the UCT (CR −0.804; p < 0.001) and “Functioning” with the AECT3mo (CR −0.824; p < 0.001). Conclusion: Although most patients with controlled disease have better quality of life, unexpectedly, quality of life remains impaired in up to one‐fourth of patients with completely controlled CSU and RA. Reasons behind this should be investigated in further studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/clt2.70026

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Documentation such as a urticaria diary (and possibly photos) can be very helpful in diagnosing and treating chronic urticaria.

    “Such documentation, such as a urticaria diary (and possibly photos), can be very helpful in diagnosing and treating the disease [16–20].”

    From Acceptance and perceived usefulness of digital health services in the management of chronic urticaria: a survey of patients and physicians (2025) · cites this paper as [18]

    The Introduction (page unavailable) says patient-reported measures help assess treatment needs and efficacy, which supports a general role for patient documentation in managing chronic urticaria. The Methods > Instruments section describes questionnaires, not a urticaria diary or photos; the paper does not say those forms of documentation help diagnose the disease. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Teledermatology reduces travel burdens and enhances timely medical advice, while chronic urticaria tracking apps improve physician-patient communication.

    “Studies show that teledermatology reduces travel burdens and enhances timely medical advice, while CU tracking apps improve physician-patient communication [18–20, 27].”

    From Acceptance and perceived usefulness of digital health services in the management of chronic urticaria: a survey of patients and physicians (2025) · cites this paper as [18]

    The Discussion (page unavailable) says chronic urticaria patients can complete outcome measures through the CRUSE app and that those measures may help guide physicians. It does not say the app improves physician–patient communication, and it does not address teledermatology, travel burdens, or timely medical advice. (LLM, conf=0.80)

    Experimental — accuracy not yet measured
  • Mobile health tools such as CRUSE® are feasible and reliable for CU monitoring.

    “The CRUSE® study demonstrated their feasibility [18, 19], with Sousa-Pinto et al. [20]. confirming their reliability.”

    From Acceptance and perceived usefulness of digital health services in the management of chronic urticaria: a survey of patients and physicians (2025) · cites this paper as [18]

    The Discussion says digital PROMs can be completed on a phone through the CRUSE app for chronic spontaneous urticaria, supporting the feasibility point. But this paper is a retrospective study of disease control and quality of life, not a CRUSE feasibility study; it cites a separate CRUSE app paper for that example. The citing sentence attributes reliability to Sousa-Pinto et al., not to this source. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [23]Weller K, Donoso T, Magerl M, et al. Development of the Angioedema Control Test—a patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema. Allergy. 2020; 75(5): 1165‐ 1177. 10.1111/all.14144 31815297 · DOI
  2. [30]Savarese L, Mormile I, Bova M, et al. Psychology and hereditary angioedema: a systematic review. Allergy Asthma Proc. 2021; 42(1): e1‐ e7. 10.2500/aap.2021.42.200073 33404395 PMC7768073 · DOI

Cited by

Sorted by citations

Authors
Neisinger, S., Salameh, P., Gutsche, A., Aulenbacher, F., Siebenhaar, F., & Maurer, M.
Affiliations
  • Humboldt-Universität zu Berlin (DE)
  • University of Nicosia (CY)
Corresponding author
Neisinger, Sophia
Venue
Clinical and Translational Allergy
Publisher
Wiley
Published
2025-01
Volume
15
Issue
1
Pages
e70026-e70026
ISSN
2045-7022 (ISSN-L)
OpenAlex
W4406068650
Cited by
8
References
36
Citations by year
2026: 4 · 2025: 4
FWCI
5.80
Type
journal article
Language
en
Open access
Locations
  • Clinical and Translational Allergy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Urticaria and Related Conditions
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Rheumatology › Eosinophilic Disorders and Syndromes
Keywords
chronic spontaneous urticaria, recurrent angioedema, disease control, quality of life, patient-reported outcome measures, UCT, AECT, pruritus, embarrassment, functioning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review